Exsilio Therapeutics
Boston, MA
Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.
exsiliotx.comCompany Details
Founded
- 2022
Employees
- Between 10 - 50 employees
Raised
- $82,000,000
Headquarters Location
- Boston, MA
Public
- No
Acquired
- No
CEO
- Tal Zaks
Company Collections
These are collections Exsilio Therapeutics is a part of. Click on the collection name to view similar companies.